Ratnakar Securities Pvt. Ltd.

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma

BSE1709.40-60.7 (-3.43 %)

PREV CLOSE ( ) 1770.10

OPEN PRICE ( ) 1772.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 145024

TODAY'S LOW / HIGH ( )1658.00 1781.70

52 WK LOW / HIGH ( )1376.75 1960.2

Select year

Particulars	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Profit Before Tax	110878.90	94084.30	44813.20	27993.70	50095.90
Adjustment	15544.00	27225.60	19749.50	18098.50	19925.40
Changes In working Capital	10621.30	-56618.20	15590.50	25640.90	8985.50
Cash Flow after changes in Working Capital	137044.20	64691.70	80153.20	71733.10	79006.80
Cash Flow from Operating Activities	121349.80	49593.30	89845.40	61703.70	65547.70
Cash Flow from Investing Activities	-6902.00	-79436.80	-57247.40	5362.20	-25888.40
Cash Flow from Financing Activities	-67101.60	23760.70	-51934.60	-59804.80	-57151.40
Net Cash Inflow / Outflow	47346.20	-6082.80	-19336.60	7261.10	-17492.10
Opening Cash & Cash Equivalents	46237.30	45082.50	62730.30	56766.10	70623.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger	NA	NA	NA	NA	NA
Cash & Cash Equivalent of Subsidiaries under liquidations	12.90	5666.90	414.50	NA	NA
Translation adjustment on reserves / op cash balalces frgn subsidiaries	NA	NA	NA	NA	NA
Effect of Foreign Exchange Fluctuations	-739.90	1570.70	1274.30	-1296.90	3635.20
Closing Cash & Cash Equivalent	92856.50	46237.30	45082.50	62730.30	56766.10

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Cash Flow

SUN PHARMACEUTICAL INDUSTRIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES